Etopophos Injection, Powder, Lyophilized, For Solution
Product Images NDC 61269-410

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etopophos (NDC 61269-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Etoposide Phosphate Chemical Structure (Etopophos Struct)

Chemical structure diagram of etoposide phosphate, the active ingredient in ETOPOPHOS injection powder, lyophilized, for solution. The molecular structure includes multiple rings and functional groups, representing the compound's detailed atomic arrangement.*

FDA Label Image

Image Etopophos100mg-lbl (Etopophos100mg Lbl)

ETOPOPHOS 100 mg etoposide phosphate injection powder, lyophilized, for intravenous use. Single-dose vial labeled by H2-Pharma, LLC, NDC 61269-410-20. The label includes dosage strength and route of administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.